Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20061986rdf:typepubmed:Citationlld:pubmed
pubmed-article:20061986lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C1442521lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C0220633lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C0140080lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C1414313lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:20061986lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:20061986pubmed:issue2lld:pubmed
pubmed-article:20061986pubmed:dateCreated2010-3-12lld:pubmed
pubmed-article:20061986pubmed:abstractTextThis study evaluated the expression profile of hepatocyte growth factor (HGF), c-Met, epidermal growth factor receptor (EGFR), insulin-like growth factor-1 receptor (IGF-1R), and vitreal and serum EGF, HGF, IGF-1 levels in patients with uveal melanoma and assessed their correlation with the clinicopathological parameters. Forty patients with uveal melanoma were included in the study. Clinicopathological parameters were evaluated with hematoxylin-eosin staining. HGF, c-Met, EGFR, and IGF-1R expressions were evaluated immunohistochemically. HGF, EGF, and IGF-1 levels were measured with enzyme-linked immunosorbent assay in vitreous and serum specimens taken at enucleation and 6 months after the enucleation. HGF, c-Met, IGF-1R, and EGFR expressions were detected in 57.5, 20, 20, and 12.5% of cases, respectively. IGF-1R expression was significantly correlated with the degree of pigmentation, necrosis, and lymphocyte infiltration (P=0.013, 0.04, and 0.017). EGFR expression was significantly correlated with the mitosis rate (P=0.02). Vitreal EGF and serum IGF-1 levels were significantly higher in patients with scleral invasion (15.72+/-29.13, 199.01+/-154.01 pg/ml, respectively) when compared with the patients without invasion (0.56+/-1.05, 33.01+/-36.52 pg/ml) (P=0.03 and 0.015). When the preoperative and postoperative serum growth factor levels were compared, the serum EGF level was found to be lower (125.93+/-62.84, 100.02+/-31.19 pg/ml, P=0.007) and the serum IGF-1 level (165.81+/-153.6, 301.35+/-131.24 pg/ml, P<0.001) was found to be higher in the postoperative 6-month specimens. Uveal melanomas express HGF, c-Met, EGFR, and IGF-1R. Vitreal growth factor levels and expression of EGFR and IGF-1R are correlated with some clinicopathological parameters. IGF-1 and EGF may have a role in the development and progression of uveal melanoma.lld:pubmed
pubmed-article:20061986pubmed:languageenglld:pubmed
pubmed-article:20061986pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061986pubmed:citationSubsetIMlld:pubmed
pubmed-article:20061986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20061986pubmed:statusMEDLINElld:pubmed
pubmed-article:20061986pubmed:monthAprlld:pubmed
pubmed-article:20061986pubmed:issn1473-5636lld:pubmed
pubmed-article:20061986pubmed:authorpubmed-author:KiratliHayyam...lld:pubmed
pubmed-article:20061986pubmed:authorpubmed-author:SöylemezogluF...lld:pubmed
pubmed-article:20061986pubmed:authorpubmed-author:SaglamArzuAlld:pubmed
pubmed-article:20061986pubmed:authorpubmed-author:HascelikGülse...lld:pubmed
pubmed-article:20061986pubmed:authorpubmed-author:Topcu-YilmazP...lld:pubmed
pubmed-article:20061986pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20061986pubmed:volume20lld:pubmed
pubmed-article:20061986pubmed:ownerNLMlld:pubmed
pubmed-article:20061986pubmed:authorsCompleteYlld:pubmed
pubmed-article:20061986pubmed:pagination126-32lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:meshHeadingpubmed-meshheading:20061986...lld:pubmed
pubmed-article:20061986pubmed:year2010lld:pubmed
pubmed-article:20061986pubmed:articleTitleCorrelation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.lld:pubmed
pubmed-article:20061986pubmed:affiliationOcular Oncology Service, Hacettepe University School of Medicine, Ankara, Turkey.lld:pubmed
pubmed-article:20061986pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20061986pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1956entrezgene:pubmedpubmed-article:20061986lld:entrezgene
entrez-gene:3082entrezgene:pubmedpubmed-article:20061986lld:entrezgene
entrez-gene:3480entrezgene:pubmedpubmed-article:20061986lld:entrezgene
entrez-gene:4233entrezgene:pubmedpubmed-article:20061986lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20061986lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20061986lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20061986lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20061986lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20061986lld:pubmed